Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Urigen Pharmaceuticals Logo
Urigen Pharmaceuticals Growth Score
83
CB Rank
114204
Heat Score
56
Urigen Pharmaceuticals designs and implements products for patients with urological ailments.
Founded
obfuscation
PrivateVenture - Series Unknown Wilmington, Delaware, United States11-50 www.urigen.com
Biotechnology
Health Care
Medical
Pharmaceutical
Overview

Urigen Pharmaceuticals
Total Funding
obfuscation
Growth Score
83
Heat Score
56

Total Funding
obfuscation
obfuscation
Venture - Series Unknown raised
obfuscation
Growth Score83
-5 pts
in past quarter
Heat Score 56
-14 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Urigen Pharmaceuticals

CB Rank
114204
Urigen Pharmaceuticals designs and implements products for patients with urological ailments.
Founded
obfuscation
PrivateVenture - Series Unknown Wilmington, Delaware, United States11-50 www.urigen.com
Biotechnology
Health Care
Medical
Pharmaceutical

Funding Rounds

Venture - Series Unknown
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation

Key People

Details

Legal Name Urigen Pharmaceuticals, Inc.
Operating Status Active
Company Type For Profit
Founders  C. Lowell Parsons
About the Company
Urigen specializes in the design and implementation of innovative products for patients with urological ailments including, specifically, the development of innovative products for amelioration of Painful Bladder Syndrome (PBS), Urethritis, Nocturia and Over Active Bladder (OAB).
Phone Number 925-280-2861
Contact Email info@urigen.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

URG101
A product candidate in clinical development for treating Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS).
URG501
A pre-clinical development candidate aimed at addressing urological ailments.

Research & Development

Urigen Pharmaceuticals is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 8
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - Urigen Pharmaceuticals Logo
Venture Round - Urigen Pharmaceuticals
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Urigen Pharmaceuticals Logo
Venture Round - Urigen Pharmaceuticals
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Urigen Pharmaceuticals Logo
Venture Round - Urigen Pharmaceuticals
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Urigen Pharmaceuticals Logo
Venture Round - Urigen Pharmaceuticals
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Urigen Pharmaceuticals Logo
Venture Round - Urigen Pharmaceuticals
—
obfuscation
— Venture - Series Unknown

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 8
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - Urigen Pharmaceuticals Logo
Venture Round - Urigen Pharmaceuticals
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Urigen Pharmaceuticals Logo
Venture Round - Urigen Pharmaceuticals
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Urigen Pharmaceuticals Logo
Venture Round - Urigen Pharmaceuticals
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Urigen Pharmaceuticals Logo
Venture Round - Urigen Pharmaceuticals
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Urigen Pharmaceuticals Logo
Venture Round - Urigen Pharmaceuticals
—
obfuscation
— Venture - Series Unknown

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 3 Contacts 3

Employee Profiles

News

News and Press

News•Jul 8, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 28, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 24, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 7, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$156.2KThis year, Urigen Pharmaceuticals is projected to spend $156.2K on IT, according to Aberdeen.

Actively Used Products

7Urigen Pharmaceuticals uses 7 technology products and services including GoDaddy Premium DNS, Starfield SSL, and  Office 365, according to G2 Stack.

Active Website Tech Count

3Urigen Pharmaceuticals is actively using 3 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m and  JotForm.
Sub-Organizations
Frequently Asked Questions

Where is Urigen Pharmaceuticals's headquarters? Urigen Pharmaceuticals is located in Wilmington, Delaware, United States.Who invested in Urigen Pharmaceuticals? Urigen Pharmaceuticals is funded by Platinum-Montaur Life Sciences.When was the last funding round for Urigen Pharmaceuticals? Urigen Pharmaceuticals closed its last funding round on
obfuscation
from a Venture - Series Unknown round.Who are Urigen Pharmaceuticals's competitors? Alternatives and possible competitors to Urigen Pharmaceuticals may include Ferring, Mapp Biopharmaceutical, and  Ironwood Pharmaceuticals.How much funding has Urigen Pharmaceuticals raised to date? Urigen Pharmaceuticals has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8fe006b 1)
|